Johnson & Johnson Taps Emergent BioSolutions to Help Manufacture Its COVID-19 Vaccine [The Motley Fool]
Emergent Biosolutions, Inc. (EBS)
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: The Motley Fool
Brian Orelli(TMFBiologyFool)Author BioDr. Orelli is a Senior Biotech Specialist. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 007.Follow @BiologyFoolJohnson & JohnsonNYSE:JNJEmergent BioSolutionsNYSE:EBSCOVID-9In addition to developing its own drugs aimed at combating bioterrorism and emerging infectious diseases,including COVID-9announcedNovavaxJohnson & Johnson's vaccine hasn't even entered clinical trials: The study isscheduled to startImage source: Getty Images.But the deal with Emergent BioSolutions is clearly a sign that Johnson & Johnson is trying to get ahead of its goal of having billion doses available. Emergent BioSolutions will begin manufacturing Johnson & Johnson's vaccine this year, well ahead of any potential approval, and Emergent BioSolutions plans to reserve large-scale manufacturing capacity to make the vaccine next year.Johnson & Johnson noted that the deal with Emergent BioSolutions was just the "first in a
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent Biosolutions, Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- ?Emergent BioSolutions (EBS) Receives a New Order from US Department of War [Yahoo! Finance]Yahoo! Finance
- New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading [The New York Times]The New York Times
- Former biotech CEO sued over COVID vaccine alleged insider trading [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday PreparednessGlobeNewswire
- Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year TransformationGlobeNewswire
EBS
Earnings
- 10/29/25 - Beat
EBS
Analyst Actions
- 12/16/25 - HC Wainwright
EBS
Sec Filings
- 1/14/26 - Form 8-K
- 1/12/26 - Form 8-K
- 1/7/26 - Form 144
- EBS's page on the SEC website